Briacell Therapeutics Corp (BCTX) Stock Price, Quote & News

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology

Sector: Healthcare

Phone: 604-921-1810

Fax: 604-921-1898

Website: briacell.com

Address:

Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

ZacksResearch Nov. 25 at 6:06 PM

$BCTX about to step into the spotlight at SABCS 🔥 BriaCell is rolling out positive biomarker and survival data across three clinical posters — including new insights from its Phase 2 study and differentiated biomarker findings from its pivotal Phase 3 program. These updates highlight how the company’s novel immunotherapies and off-the-shelf cell-based approaches could help deliver more precisely targeted treatment options for metastatic breast cancer. See the complete stock outlook here👉 https://www.zacks.com/stock/quote/BCTX?cid=sm-stocktwits-0-quote_overview-oc-22469&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_22469

0 · Reply

DunkenInvest Nov. 25 at 3:11 PM

$BCTX when we hit 150$ I'm happy. I'm never gonna be happy I guess 🤣 #letsgoBCTX

1 · Reply

JJBurch Nov. 25 at 2:52 PM

$OSRH congrats to all. The revaluation phase is barely started. Recent $10 price target given. Long long way to go $IXHL watch for major spike today. Manipulation is so laughably obvious. Watch move from .32 to above .35-.38 today prior to news. Big volume coming. $QCLS they are about to sell their bio assets for $20M cash. That will be a major mover. $BCTX price target of $150. Cancer cure way under the radar obviously. GLTA

0 · Reply

Ernesto62 Nov. 25 at 1:11 PM

$BCTX $IXHL $QCLS bullshit

0 · Reply

JJBurch Nov. 25 at 1:08 PM

$BCTX $IXHL $QCLS All three now in serious acceleration mode Congrats to all who followed! LFG!!!

0 · Reply

SmallCapVoice Nov. 25 at 12:49 PM

$BCTX is set to showcase major progress at SABCS 2025 with three posters highlighting positive Phase 2, strong biomarker data and momentum in its pivotal Phase 3 study. Fast Track status adds to the significance. Investors will want this on their radar. https://www.globenewswire.com/news-release/2025/11/25/3194231/0/en/BriaCell-to-Highlight-Positive-Phase-2-Phase-3-Clinical-Data-at-SABCS-2025.html

0 · Reply

Stock2Luv Nov. 25 at 3:30 AM

$BCTX https://www.msn.com/en-us/health/other/cancer-drug-made-20-000-times-more-potent-in-breakthrough/ar-AA1PNqfY?ocid=msedgdhp&pc=U531&cvid=69252220b47a4d89aaa882dfd28a7eb2&ei=11

0 · Reply

JJBurch Nov. 24 at 3:49 PM

$OSRH breakout confirmed Hold on and enjoy!! $IXHL absolutely the next to go. Hurry and load up $BCTX loading zone $QCLS Congrats to all. Making money together is the best. The very best.

1 · Reply

student56 Nov. 24 at 2:10 PM

$BCTX IN

0 · Reply

2maligators Nov. 24 at 1:01 PM

$BCTX 👀

0 · Reply

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

Nov 20, 2025, 7:30 AM EST - 5 days ago

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Nov 18, 2025, 7:30 AM EST - 7 days ago

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

Nov 7, 2025, 7:30 AM EST - 18 days ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

Nov 4, 2025, 7:30 AM EST - 21 days ago

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

Oct 22, 2025, 7:30 AM EDT - 4 weeks ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

Oct 21, 2025, 7:50 AM EDT - 5 weeks ago

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

Oct 21, 2025, 7:30 AM EDT - 5 weeks ago

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

Oct 20, 2025, 7:30 AM EDT - 5 weeks ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 13, 2025, 7:30 AM EDT - 6 weeks ago

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

Oct 3, 2025, 7:30 AM EDT - 7 weeks ago

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

Aug 26, 2025, 7:30 AM EDT - 3 months ago

BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

Aug 25, 2025, 7:30 AM EDT - 3 months ago

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

Aug 21, 2025, 12:00 PM EDT - 3 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 13, 2025, 7:30 AM EDT - 3 months ago

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Jul 31, 2025, 7:30 AM EDT - 4 months ago

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

Jul 30, 2025, 7:30 AM EDT - 4 months ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 29, 2025, 7:30 AM EDT - 4 months ago

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

Jul 25, 2025, 7:30 AM EDT - 4 months ago

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

Jul 16, 2025, 4:05 PM EDT - 4 months ago

BriaCell Therapeutics Announces Closing of $15 million Public Offering

Jul 15, 2025, 3:05 PM EDT - 4 months ago

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

Jul 15, 2025, 7:30 AM EDT - 4 months ago

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

Jul 11, 2025, 7:30 AM EDT - 4 months ago

BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

Jul 10, 2025, 7:30 AM EDT - 4 months ago

BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient

Jul 9, 2025, 7:30 AM EDT - 4 months ago

BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study

Jul 8, 2025, 7:30 AM EDT - 5 months ago

BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer

Jul 2, 2025, 7:30 AM EDT - 5 months ago

BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven

Jun 24, 2025, 7:30 AM EDT - 5 months ago

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

Jun 4, 2025, 7:30 AM EDT - 6 months ago

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

Jun 2, 2025, 7:30 AM EDT - 6 months ago

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025

May 27, 2025, 7:30 AM EDT - 6 months ago

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor

May 23, 2025, 7:30 AM EDT - 6 months ago

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025

May 20, 2025, 7:30 AM EDT - 6 months ago

BriaCell CEO Letter to Shareholders

Apr 30, 2025, 7:30 AM EDT - 7 months ago

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

Apr 28, 2025, 4:05 PM EDT - 7 months ago

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

Apr 28, 2025, 7:30 AM EDT - 7 months ago

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

Apr 24, 2025, 8:00 PM EDT - 7 months ago

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

Apr 24, 2025, 10:11 AM EDT - 7 months ago

Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher

Apr 24, 2025, 7:30 AM EDT - 7 months ago

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

Apr 23, 2025, 7:30 AM EDT - 7 months ago

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

Apr 22, 2025, 7:30 AM EDT - 7 months ago

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

Apr 16, 2025, 7:30 AM EDT - 7 months ago

BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer

Mar 26, 2025, 8:00 AM EDT - 8 months ago

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference

Mar 20, 2025, 8:00 AM EDT - 8 months ago

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell's Phase 3 Study in Metastatic Breast Cancer

Feb 5, 2025, 6:15 PM EST - 10 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Feb 5, 2025, 4:05 PM EST - 10 months ago

BriaCell Therapeutics Announces Closing of Public Offering

Feb 3, 2025, 7:59 PM EST - 10 months ago

BriaCell Therapeutics Announces Pricing of Public Offering

Feb 3, 2025, 4:45 PM EST - 10 months ago

BriaCell Therapeutics Announces Proposed Public Offering of Common Shares

Feb 3, 2025, 7:30 AM EST - 10 months ago

BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™

Jan 27, 2025, 6:42 PM EST - 10 months ago

BriaCell Announces Completion of 15:1 Share Consolidation

ZacksResearch Nov. 25 at 6:06 PM

0 · Reply

DunkenInvest Nov. 25 at 3:11 PM

$BCTX when we hit 150$ I'm happy. I'm never gonna be happy I guess 🤣 #letsgoBCTX

1 · Reply

JJBurch Nov. 25 at 2:52 PM

0 · Reply

Ernesto62 Nov. 25 at 1:11 PM

$BCTX $IXHL $QCLS bullshit

0 · Reply

JJBurch Nov. 25 at 1:08 PM

$BCTX $IXHL $QCLS All three now in serious acceleration mode Congrats to all who followed! LFG!!!

0 · Reply

SmallCapVoice Nov. 25 at 12:49 PM

0 · Reply

Stock2Luv Nov. 25 at 3:30 AM

$BCTX https://www.msn.com/en-us/health/other/cancer-drug-made-20-000-times-more-potent-in-breakthrough/ar-AA1PNqfY?ocid=msedgdhp&pc=U531&cvid=69252220b47a4d89aaa882dfd28a7eb2&ei=11

0 · Reply

JJBurch Nov. 24 at 3:49 PM

$OSRH breakout confirmed Hold on and enjoy!! $IXHL absolutely the next to go. Hurry and load up $BCTX loading zone $QCLS Congrats to all. Making money together is the best. The very best.

1 · Reply

student56 Nov. 24 at 2:10 PM

$BCTX IN

0 · Reply

2maligators Nov. 24 at 1:01 PM

$BCTX 👀

0 · Reply

DunkenInvest Nov. 24 at 10:01 AM

$BCTX there's still time to save my Christmas 🤣 Come on now dawg 💸

0 · Reply

superguild Nov. 22 at 6:25 AM

$BCTX burch has only one gify. Guess he has a crush on leo

0 · Reply

JJBurch Nov. 21 at 7:34 PM

$BCTX $IXHL $QCLS Two out of three starting their moves is a great start!!!! Congrats all

1 · Reply

JediGreen Nov. 21 at 9:07 AM

$BCTX My past experiences with stocks with so little shares to go around and when the stampede of investors all of a sudden want to be apart of a stock with positive phase 3 results its crazy. I’ve tried to get in stokes before on phass 3s and I was never able to get orders filled and get in them because the shares are baught up so fast and definitely could see a huge gap up on positive phase 3 results. Have fun if you are short margin calls and not only losing your money but owing your broker money. 😆

1 · Reply

JediGreen Nov. 21 at 5:56 AM

$BCTX Say if there is an offering in December. probably be a favorable offering. Phase 3 read out in the first half a 2026 could happen any day starting 2026. Bullish BABY

0 · Reply

Kirubin Nov. 20 at 6:02 PM

$BCTX 😂😂😂🤭

0 · Reply

ZacksResearch Nov. 20 at 4:36 PM

$BCTX just made a big move into AI-driven cancer drug discovery 👀 BriaCell’s BriaPro unit is teaming up with Receptor.AI to design isoform-selective kinase inhibitors — a major push beyond its cell-based immunotherapy work. The goal? Tap AI-driven molecular design to expand the small-molecule pipeline and sharpen precision in targeting tough oncology pathways. See the complete stock outlook here👉 https://www.zacks.com/stock/quote/BCTX?cid=sm-stocktwits-0-quote_overview-oc-21904&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_21904

0 · Reply

JediGreen Nov. 20 at 4:25 PM

$BCTX

0 · Reply

JJBurch Nov. 20 at 3:40 PM

$IXHL & $BCTX This is it Buckle up Both are taking off!!!!!!!!!

1 · Reply

MoeMaze Nov. 20 at 1:58 PM

$BCTX $BCTX “So, you guys decided to dive the stock down by over 40% last week, like a SUBMARINE sinking deep, and now with the good news, it’s barely going to launch back up, more like a mid-range ROCKET that’s out of fuel! Classic move, right?” #briacell from hell #Stocks @BriaCell

1 · Reply

JJBurch Nov. 20 at 1:22 PM

$QCLS ok friends! It’s time to make some money! Congratulations $IXHL $BCTX These three are millionaire makers.

2 · Reply

JJBurch Nov. 20 at 1:04 PM

$BCTX YES!!!! MY #1 holding for November is catching FIRE!! $IXHL so will this one I’ve been banging the table on both of these this week Let’s get paid!!! $PF $XBI $NVDA

0 · Reply

Market Cap	15.07M
Revenue (ttm)	0.00
Net Income (ttm)	-26.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	43,747
Avg Vol	74,588
Day's Range	N/A - N/A
Shares Out	1.88M
Stochastic %K	42%
Beta	1.21
Analysts	Hold
Price Target	$40.00